In a previous study [18], among 14,095 patients, the axillary recurrence rate was 0.51% and in multivariate analysis, the occurrence of axillary recurrence was significantly correlated with grade 2 or 3 BC, absence of radiotherapy and BC subtype (ER-negative Her2-positive). The gene discussed is ERBB2; the disease is breast cancer.